162 related articles for article (PubMed ID: 24674192)
1. The efficacy of external beam radiotherapy and stereotactic body radiotherapy for painful spinal metastases from renal cell carcinoma.
Hunter GK; Balagamwala EH; Koyfman SA; Bledsoe T; Sheplan LJ; Reddy CA; Chao ST; Djemil T; Angelov L; Videtic GMM
Pract Radiat Oncol; 2012; 2(4):e95-e100. PubMed ID: 24674192
[TBL] [Abstract][Full Text] [Related]
2. Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma.
Balagamwala EH; Angelov L; Koyfman SA; Suh JH; Reddy CA; Djemil T; Hunter GK; Xia P; Chao ST
J Neurosurg Spine; 2012 Dec; 17(6):556-64. PubMed ID: 23020208
[TBL] [Abstract][Full Text] [Related]
3. Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
Pielkenrood BJ; van der Velden JM; van der Linden YM; Bartels MMT; Kasperts N; Verhoeff JJC; Eppinga WSC; Gal R; Verlaan JJ; Verkooijen HML
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):358-367. PubMed ID: 33333200
[TBL] [Abstract][Full Text] [Related]
4. A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases.
Jhaveri PM; Teh BS; Paulino AC; Blanco AI; Lo SS; Butler EB; Amato RJ
Acta Oncol; 2012 May; 51(5):584-8. PubMed ID: 22248089
[TBL] [Abstract][Full Text] [Related]
5. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Amini A; Altoos B; Bourlon MT; Bedrick E; Bhatia S; Kessler ER; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
Pract Radiat Oncol; 2015; 5(6):e589-e596. PubMed ID: 26142027
[TBL] [Abstract][Full Text] [Related]
6. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy".
Hoerner-Rieber J; Duma M; Blanck O; Hildebrandt G; Wittig A; Lohaus F; Flentje M; Mantel F; Krempien R; Eble MJ; Kahl KH; Boda-Heggemann J; Rieken S; Guckenberger M
J Thorac Dis; 2017 Nov; 9(11):4512-4522. PubMed ID: 29268521
[TBL] [Abstract][Full Text] [Related]
8. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
[TBL] [Abstract][Full Text] [Related]
9. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of stereotactic body radiotherapy for painful bone metastases: Evidence from randomized controlled trials.
Wang Z; Li L; Yang X; Teng H; Wu X; Chen Z; Wang Z; Chen G
Front Oncol; 2022; 12():979201. PubMed ID: 36338685
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors associated with pain palliation after spine stereotactic body radiation therapy.
Puvanesarajah V; Lo SL; Aygun N; Liauw JA; Jusué-Torres I; Lina IA; Hadelsberg U; Elder BD; Bydon A; Bettegowda C; Sciubba DM; Wolinsky JP; Rigamonti D; Kleinberg LR; Gokaslan ZL; Witham TF; Redmond KJ; Lim M
J Neurosurg Spine; 2015 Nov; 23(5):620-629. PubMed ID: 26230422
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Pain Relief for Bone Metastases: A Systematic Review and Meta-Analysis.
Song X; Wei J; Sun R; Jiang W; Chen Y; Shao Y; Gu W
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):909-921. PubMed ID: 36273520
[TBL] [Abstract][Full Text] [Related]
14. Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT).
Altoos B; Amini A; Yacoub M; Bourlon MT; Kessler EE; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
Radiat Oncol; 2015 Oct; 10():218. PubMed ID: 26510665
[TBL] [Abstract][Full Text] [Related]
15. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy.
Nguyen QN; Shiu AS; Rhines LD; Wang H; Allen PK; Wang XS; Chang EL
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1185-92. PubMed ID: 19632064
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body and Conventional Radiotherapy for Painful Bone Metastases: A Systematic Review and Meta-Analysis.
Bindels BJJ; Mercier C; Gal R; Verlaan JJ; Verhoeff JJC; Dirix P; Ost P; Kasperts N; van der Linden YM; Verkooijen HM; van der Velden JM
JAMA Netw Open; 2024 Feb; 7(2):e2355409. PubMed ID: 38345820
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases.
Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):556-63. PubMed ID: 25680599
[TBL] [Abstract][Full Text] [Related]
18. Palliative Efficacy of High-Dose Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Painful Non-Spine Bone Metastases: A Propensity Score-Matched Analysis.
Ito K; Taguchi K; Nakajima Y; Ogawa H; Murofushi KN
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011008
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
[TBL] [Abstract][Full Text] [Related]
20. Radiosurgery for Treatment of Renal Cell Metastases to Spine: A Systematic Review of the Literature.
Smith BW; Joseph JR; Saadeh YS; La Marca F; Szerlip NJ; Schermerhorn TC; Spratt DE; Younge KC; Park P
World Neurosurg; 2018 Jan; 109():e502-e509. PubMed ID: 29038086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
